SERMORELIN 10MG
Sermorelin 10MG is a defined synthetic research peptide supplied exclusively for controlled laboratory and analytical investigations involving molecular characterization, growth hormone-releasing hormone receptor interactions, endocrine-associated cellular signaling pathways, peptide stability, and experimental biochemical research.
Research Context
Sermorelin is a synthetic 29-amino-acid peptide corresponding to the biologically active N-terminal fragment of human growth hormone-releasing hormone (GHRH). It is studied in laboratory research involving endocrine-associated molecular pathways, peptide-receptor interactions, and cellular signaling mechanisms.
Its defined molecular structure supports controlled investigations of growth hormone-releasing hormone receptor (GHRHR) binding characteristics, intracellular cyclic AMP signaling pathways, and peptide-mediated biochemical regulatory processes. Sermorelin is investigated as a GHRH receptor agonist in experimental models examining receptor-mediated molecular communication and endocrine-associated signaling.
Preclinical and biochemical investigations also examine peptide structure-function relationships, receptor activation mechanisms, and growth hormone-associated molecular regulation. Research findings should be interpreted within their experimental context and do not independently establish safety or effectiveness for unapproved applications.
Laboratory Research Information
Laboratory studies may examine molecular identification, peptide stability, GHRH receptor-interaction models, intracellular signaling mechanisms, and experimental assay behavior.
Research may also involve analytical characterization, chromatographic separation, receptor-binding properties, endocrine-associated molecular signaling, and compound-specific biochemical interactions under controlled conditions.
Additional investigations may evaluate peptide degradation, receptor-associated cellular responses, cyclic AMP-related signaling pathways, and experimental endocrine regulatory mechanisms. Observations should be interpreted within the design and limitations of the relevant experimental study.
Product Specifications
| Specification | Details |
|---|---|
| Product Name | SERMORELIN 10MG |
| Brand | Soltovia |
| Alternative Name | GRF (1-29) NH2 / GHRH (1-29) Amide / Geref |
| Compound Type | Synthetic growth hormone-releasing hormone fragment |
| Research Profile | GHRH receptor signaling, endocrine-associated molecular pathways, and peptide characterization research |
| Molecular Weight | Approximately 3357.9 Da (reference free-peptide form) |
| Molecular Formula | C149H246N44O42S (reference free-peptide form) |
| CAS Number | 86168-78-7 (reference free-peptide form) |
| PubChem CID | 16132413 |
| Amino Acid Count | 29 |
| Amino Acid Sequence | Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 |
| Single-Letter Sequence | YADAIFTNSYRKVLGQLSARKLLQDIMSR |
| Structural Characteristics | Linear 29-amino-acid GHRH-derived peptide with a C-terminal amide |
| Parent Hormone | Human Growth Hormone-Releasing Hormone (GHRH) |
| Research Receptor | Growth Hormone-Releasing Hormone Receptor (GHRHR) |
| Research Classification | Synthetic GHRH receptor agonist research peptide |
| Research Pathways | GHRH receptor signaling, cyclic AMP pathways, endocrine-associated molecular regulation, and peptide-receptor interactions |
| Research Applications | Peptide characterization, receptor-interaction studies, cellular signaling assays, and experimental biochemical investigations |
| Available Size | 10MG |
| Purity | Refer to batch-specific COA |
| Testing Method | Refer to batch-specific COA |
| Laboratory | Refer to batch-specific COA |
| Storage Conditions | Follow verified manufacturer specifications |
For laboratory research use only. Not for human or veterinary use. Not intended for human consumption or clinical applications. This material does not provide medical or consumer-use guidance.
Reviews
There are no reviews yet.